Dowling & Yahnke LLC Chimerix Inc Transaction History
Dowling & Yahnke LLC
- $215 Million
- Q3 2022
A detailed history of Dowling & Yahnke LLC transactions in Chimerix Inc stock. As of the latest transaction made, Dowling & Yahnke LLC holds 64,055 shares of CMRX stock, worth $547,029. This represents 0.06% of its overall portfolio holdings.
Number of Shares
64,055
Previous 64,055
-0.0%
Holding current value
$547,029
Previous $133,000
6.77%
% of portfolio
0.06%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CMRX
# of Institutions
16Shares Held
7.43MCall Options Held
0Put Options Held
0-
Magnetar Financial LLC Evanston, IL3.92MShares$33.5 Million1.23% of portfolio
-
Jpmorgan Chase & CO New York, NY1.52MShares$13 Million0.0% of portfolio
-
Black Rock Inc. New York, NY907KShares$7.74 Million0.0% of portfolio
-
Cibra Capital LTD London, X0732KShares$6.25 Million2.13% of portfolio
-
Credit Suisse Ag Zurich, V894KShares$802,7590.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $748M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...